Your browser doesn't support javascript.
loading
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
Cencini, Emanuele; Tucci, Alessandra; Puccini, Benedetta; Cavallo, Federica; Luminari, Stefano; Usai, Sara Veronica; Fabbri, Alberto; Pennese, Elsa; Marino, Dario; Zilioli, Vittorio Ruggero; Balzarotti, Monica; Petrucci, Luigi; Tafuri, Agostino; Arcari, Annalisa; Botto, Barbara; Zanni, Manuela; Hohaus, Stefan; Sartori, Roberto; Merli, Michele; Gini, Guido; Al Essa, Wael; Musurca, Gerardo; Tani, Monica; Nassi, Luca; Daffini, Rosa; Mammi, Caterina; Marcheselli, Luigi; Bocchia, Monica; Spina, Michele; Merli, Francesco.
Afiliação
  • Cencini E; Unit of Hematology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy.
  • Tucci A; Hematology Division, ASST Spedali Civili Brescia, Brescia, Italy.
  • Puccini B; Hematology Department, Careggi Hospital and University of Florence, Firenze, Italy.
  • Cavallo F; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU "Città della Salute e della Scienza di Torino", Torino, Italy.
  • Luminari S; Hematology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Usai SV; Department CHIMOMO, University of Modena and Reggio Emilia, Reggio Emilia, Italy.
  • Fabbri A; Division of Hematology, Ospedale Oncologico Armando Businco, Cagliari, Italy.
  • Pennese E; Unit of Hematology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy.
  • Marino D; Lymphoma Unit, Department of Hematology, Ospedale Spirito Santo, Pescara, Italy.
  • Zilioli VR; Oncology 1 Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
  • Balzarotti M; Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Petrucci L; Department of Medical Oncology and Hematology, IRCCS Humanitas Research Hospital, Milano, Italy.
  • Tafuri A; Insitute of Hematology, Department of Tanslational and Precision Medicine "La Sapienza", University of Roma, Roma, Italy.
  • Arcari A; Hematology, University Hospital S.Andrea-Sapienza, Roma, Italy.
  • Botto B; Hematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy.
  • Zanni M; Division of Hematology, Città della Salute e della Scienza Hospital and University, Torino, Italy.
  • Hohaus S; Hematology Unit, Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy.
  • Sartori R; University Policlinico Gemelli Foundation-IRCCS, Catholic University of Sacred Heart, Roma, Italy.
  • Merli M; Oncohematology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy.
  • Gini G; Division of Hematology, Ospedale di Circolo e Fondazione Macchi - ASST Sette Laghi, University of Insubria, Varese, Italy.
  • Al Essa W; Clinic of Hematology AOU Ospedali Riuniti Ancona, Università Politecnica delle Marche, Ancona, Italy.
  • Musurca G; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, and Azienda Ospedaliero-Universitaria Maggiore della Carità Novara, Novara, Italy.
  • Tani M; Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Nassi L; Hematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy.
  • Daffini R; Hematology Department, Careggi Hospital and University of Florence, Firenze, Italy.
  • Mammi C; Hematology Division, ASST Spedali Civili Brescia, Brescia, Italy.
  • Marcheselli L; Gruppo Amici dell'Ematologia GRADE-Onlus Foundation, Reggio Emilia, Italy.
  • Bocchia M; Fondazione Italiana Linfomi Onlus, Modena, Italy.
  • Spina M; Unit of Hematology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy.
  • Merli F; Division of Medical Oncology and Immunerelated Tumors, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Hematol Oncol ; 41(1): 78-87, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36177902

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article